The integrated care pathway for melanoma: the Istituto Dermopatico dell’Immacolata experience in Rome

Il percorso diagnostico terapeutico e assistenziale nella gestione del paziente con melanoma cutaneo: l’esperienza dell’IDI di Roma

  • Francesco Ricci Unità Operativa Funzionale del Melanoma, IDI-IRCCS, Roma - Italy
  • Alessio Caggiati Unità Operativa Complessa Chirurgia Plastica, IDI-IRCCS, Roma - Italy
  • Vincenzo Ziparo Unità Operativa Complessa Chirurgia Generale, IDI-IRCCS, Roma - Italy
  • Maurizio Elia Unità Operativa Complessa Chirurgia Generale, IDI-IRCCS, Roma - Italy
  • Giandomenico Russo Oncologia Molecolare, IDI-IRCCS, Roma - Italy https://orcid.org/0000-0002-7718-9687
  • Stefania D'Atri Oncologia Molecolare, IDI-IRCCS, Roma - Italy https://orcid.org/0000-0001-9852-7377
  • Cristina Maria Failla Immunologia Sperimentale, IDI-IRCCS, Roma - Italy https://orcid.org/0000-0001-5991-8914
  • Annarita Panebianco Direzione Sanitaria, IDI-IRCCS, Roma - Italy
  • Giorgio Annessi Laboratorio di Istopatologia, IDI-IRCCS, Roma - Italy
  • Francesca Passarelli Laboratorio di Istopatologia, IDI-IRCCS, Roma - Italy
  • Marie Perez Laboratorio di Istopatologia, IDI-IRCCS, Roma - Italy
  • Tommaso Tartaglione Unità Operativa Complessa Radiologia e Diagnostica per Immagini, IDI-IRCCS, Roma - Italy https://orcid.org/0000-0003-3896-4078
  • Giovanni Di Lella Day Surgery Dermatologico, IDI-IRCCS, Roma - Italy
  • Sabatino Pallotta Unità Operativa Complessa V Divisione Dermatologica, IDI-IRCCS, Roma - Italy
  • Cinzia Mazzanti Unità Operativa Complessa I Divisione Dermatologica, IDI-IRCCS, Roma - Italy
  • Maurizio Nudo Unità Operativa Semplice Chirurgia Dermatologica, IDI-IRCCS, Roma - Italy
  • Cristina Fortes Unità di Epidemiologia, Registri, Clinical Trial Center, Statistica, IDI-IRCCS, Roma - Italy
  • Damiano Abeni Unità di Epidemiologia, Registri, Clinical Trial Center, Statistica, IDI-IRCCS, Roma - Italy https://orcid.org/0000-0002-0167-7617
  • Federica De Galitiis Unità Operativa Complessa Oncologia, IDI-IRCCS, Roma - Italy
  • Paolo Marchetti Oncologia Medica, Università degli Studi di Roma “La Sapienza”, Roma - Italy https://orcid.org/0000-0001-5170-9579
Keywords: Continuity of care, Integrated Care Pathway, Melanoma, Patient care

Abstract

Introduction: The Integrated Care Pathway (ICP) represents a multidisciplinary outline of anticipated care, placed in an appropriate timeframe, to support patients with specific conditions or symptoms. The aim of this paper is to define the ICP for patients with melanoma referring to the “Istituto Dermopatico dell’Immacolata-IRCCS di Roma e Villa Paola” (“Center”).
Methods and results: A multidisciplinary group (oncologists, dermatologists, surgeons, pathologists etc.) was defined as well as a facilitator to act as a link between all experts. The first step of ICP development was a review of current practice for patients with melanoma referring to the Center. This first step had the scope to define the multidisciplinary process map (a “picture” of the care plan) for patients with melanoma. The process map defined: i) the activities performed during delivery of care to the patients, ii) the responsibilities for these activities and iii) potential problem areas or opportunities for improvements. The process map formed the basis of the final ICP document.
Conclusion: The adoption of melanoma ICP will allow the multidisciplinary group to ensure that clinical guidelines and available evidence are incorporated into everyday practice. (Oncology, HTA & Market Access)

References

NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma. Version 1.2019. January 17, 2019.

Dummer R, Hauschild A, Lindenblatt N et al.; ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015 Sep;26 Suppl 5:v126-32.

Garbe C, Peris K, Hauschild A et al.; European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organisation for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016. Eur J Cancer. 2016 Aug;63:201-17.

AIOM (Associazione Italiana di Oncologia Medica). Linee guida Melanoma. Edizione 2018.

http://e-p-a.org/sito-internet-e-p-a/percorsi-diagnostici-terapeutici-e-assistenziali-pdta/ Accesso Novembre 2017.

Gershenwald JE, Scolyer RA, Hess KR et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017 Nov;67(6):472-92.

Wong SL, Faries MB, Kennedy EB et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. Ann Surg Oncol. 2018 Feb;25(2):356-77.

Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ 1998 Jan 10;316(7125):133-7

Published
2019-06-07
How to Cite
1.
Ricci F, Caggiati A, Ziparo V, Elia M, Russo G, D’AtriS, Failla CM, Panebianco A, Annessi G, Passarelli F, Perez M, Tartaglione T, Di LellaG, Pallotta S, Mazzanti C, Nudo M, Fortes C, Abeni D, De GalitiisF, Marchetti P. The integrated care pathway for melanoma: the Istituto Dermopatico dell’Immacolata experience in Rome. Abtpn [Internet]. 7Jun.2019 [cited 25Jan.2020];6(1):39-7. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/289
Section
Original research article